✦ LIBER ✦

IFN alpha 2b and ribavirin in naive patients with HCV type 1 chronic hepatitis: results after 6 months of therapy

✍ Scribed by G. Benetti; G. Ramella; A. Tagger; M.L. Ribero; L. Tortora; M. Borzio; S. Fargion; G. Croce; P. Del Poggio; G. Bellati; L. Roffi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon alph

✍ J. Juszczyk; B. Bolewska; J. Cianciara; J. Jablonska; P. Zaborowski; D. Niedzial 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

O.127 Phase 2b interim (week 12) results

✍ Y. Benhamou; S. Zeuzem; D. Shouval; V. Bain; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Combination therapy with ribavirin and i

✍ F Lunel; P Cresta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Early clearance kinetics of hepatitis C

✍ L.C. Da Silva; S.K. Ono-Nita; F.J. Carrilho; J.E.M. Medeiros-Filho; J.R.R. Pinho 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Preliminary results of naive combination

✍ B. Lavezzo; A. Franchello; A. Smedile; D. Cocchis; E. David; V. Ghisetti; M. Tor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

751 The safety and efficacy of viramidin

✍ Y. Benhamou; P. Pockros; M. Rodrieuez-Torres; S. Gordon; M. Shiffinan; Y. Lurie; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB